Twenty Years of G-CSF

Clinical and Nonclinical Discoveries

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Twenty Years of G-CSF by , Springer Basel
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783034802185
Publisher: Springer Basel Publication: January 5, 2012
Imprint: Springer Language: English
Author:
ISBN: 9783034802185
Publisher: Springer Basel
Publication: January 5, 2012
Imprint: Springer
Language: English

Granulocyte colony-stimulating factor (G-CSF or GCSF) is a secreted glycoprotein that stimulates the proliferation and differentiation of granulocyte precursor cells, and induces mobilization of peripheral blood progenitor cells from the bone marrow. Development of recombinant human G-CSF has had a profound impact on the treatment of many diseases, including severe chronic neutropenia and cancer, and has enabled peripheral stem cell transplantation to supplant bone marrow transplantation in the autologous setting.

This Milestones in Drug Therapy volume describes the experience of the last 20 years of treatment with recombinant human G-CSF, including the basic science, the use of recombinant human G-CSF in both the oncology and nononcology settings, and the safety and economics of its use. Many of the authors were the original investigators of recombinant human G-CSF and other authors are key researchers who provide their outlook for the next 20 years for use of and research with recombinant human G-CSF.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Granulocyte colony-stimulating factor (G-CSF or GCSF) is a secreted glycoprotein that stimulates the proliferation and differentiation of granulocyte precursor cells, and induces mobilization of peripheral blood progenitor cells from the bone marrow. Development of recombinant human G-CSF has had a profound impact on the treatment of many diseases, including severe chronic neutropenia and cancer, and has enabled peripheral stem cell transplantation to supplant bone marrow transplantation in the autologous setting.

This Milestones in Drug Therapy volume describes the experience of the last 20 years of treatment with recombinant human G-CSF, including the basic science, the use of recombinant human G-CSF in both the oncology and nononcology settings, and the safety and economics of its use. Many of the authors were the original investigators of recombinant human G-CSF and other authors are key researchers who provide their outlook for the next 20 years for use of and research with recombinant human G-CSF.

More books from Springer Basel

Cover of the book And Yet It Is Heard by
Cover of the book And Yet It Is Heard by
Cover of the book Berichte zu Pflanzenschutzmitteln 2011 by
Cover of the book The Scholar and the State: In Search of Van der Waerden by
Cover of the book Molecular, Clinical and Environmental Toxicology by
Cover of the book Infection, Immune Homeostasis and Immune Privilege by
Cover of the book Mathematics in the 21st Century by
Cover of the book Recent Developments of Mathematical Fluid Mechanics by
Cover of the book Around and Beyond the Square of Opposition by
Cover of the book IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity by
Cover of the book Control and Optimization with PDE Constraints by
Cover of the book Matrix Metalloproteinase Inhibitors by
Cover of the book Influenza Virus Sialidase - A Drug Discovery Target by
Cover of the book Bortezomib in the Treatment of Multiple Myeloma by
Cover of the book Influenza Vaccines for the Future by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy